Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Before the Affordable Care Act (ACA) became law, health plans relied on an employer-centric model that was focused entirely on groups rather than members.
Donald Searing, Ph.D., Senior Director of Product Evangelism for Colibrium
Blacksburg, Va.-based eBroselow today launched a new clinical tool to help medical transport teams and emergency department staff safely administer drugs during acute emergency situations.
Retailers like Target are increasingly transforming into small distribution centers, shipping items to customers' homes and serving as a pick up location for online orders, reports the Chicago Tribune.
GlaxoSmithKline subsidiary ViiV Healthcare achieved positive results in its Phase III clinical trials for a new two-drug regimen to treat HIV, reports The Wall Street Journal.
Basel, Switzerland-based Novartis on Monday signed a licensing agreement with Conatus Pharmaceuticals to co-develop a fatty liver disease drug, reports Reuters.
When dieting, individuals must consider not only how much they eat, but also what type of food they should consume to shed pounds. Similarly, when health systems attempt to reduce supply chain costs, they should consider both the volume of…
Tens of millions of Americans have purchased prescription drugs from outside of the U.S. and imported them into the country, reports Kaiser Health News.
The holiday season is perhaps the busiest time of year for the retail sector. Between Black Friday, Cyber Monday and many well-timed new product launches, we can assume that the supply chain is working overtime.
Mike Duffy, President, Hospital Solutions and Global Supply Chain at Cardinal Health
Bob Kocher, MD, and Bryan Roberts are partners at the venture capital firm Venrock, where they specialize in healthcare-related investment opportunities. In an article for Fortune, Dr. Kocher and Mr. Roberts share 10 healthcare predictions for 2017.
Clovis Oncology on Monday earned accelerated approval from the Food and Drug Administration for its ovarian cancer drug Rubracam, reports Reuters.